Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.
Hajar Sadat Mirsafaei
MetadataShow full item record
Women of childbearing age who have developed chronic hepatitis B (CHB) infection, especially HBeAg-positive highly viraemic pregnant women, are largely responsible for the familial transmission of the infection. Therefore, choosing the most effective and safest antiviral medications to manage pregnant CHB patients is of crucial importance.